News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS), Merck & Co., Inc. (MRK) In Talks To Swap $5 Billion Business Units


1/9/2014 7:41:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Novartis AG (NOVN) is in talks with Merck & Co. to trade its animal-health and human vaccines businesses for the New Jersey drugmaker’s over-the-counter health-products unit, people familiar with the matter said. The swap would fit strategies at both companies -- and within the industry -- to focus on core strengths and get rid of other business lines. The two drugmakers may each trade about $5 billion in assets to do so, said one of the people, who asked not to be named because the process is private.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Forbes
Read at Seeking Alpha
Read at Nasdaq
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES